M
Mohan Somasundaran
Researcher at University of Massachusetts Medical School
Publications - 56
Citations - 7624
Mohan Somasundaran is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Virus & Cytotoxic T cell. The author has an hindex of 25, co-authored 50 publications receiving 6295 citations.
Papers
More filters
Journal ArticleDOI
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Wenhui Li,Michael Moore,Natalya Vasilieva,Jianhua Sui,Swee Kee Wong,Michael A. Berne,Mohan Somasundaran,John L. Sullivan,Katherine Luzuriaga,Thomas C. Greenough,Hyeryun Choe,Michael Farzan +11 more
TL;DR: It is found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells, indicating that ACE2 is a functional receptor for SARS-CoV.
Journal ArticleDOI
Viremic relapse after HIV-1 remission in a perinatally infected child
Katherine Luzuriaga,Carrie Ziemniak,Keri B. Sanborn,Mohan Somasundaran,Kaitlin Rainwater-Lovett,John W. Mellors,Daniel I. S. Rosenbloom,Deborah Persaud +7 more
TL;DR: Recently the “Mississippi Child” was reported as having a prolonged clearance of HIV viremia after the initiation of antiretroviral therapy shortly after birth.
Journal ArticleDOI
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.
Wenhui Li,Thomas C. Greenough,Michael Moore,Natalya Vasilieva,Mohan Somasundaran,John L. Sullivan,Michael Farzan,Hyeryun Choe +7 more
TL;DR: It is found that, compared to human ACE2, murine ACE2 less efficiently bound the S1 domain of SARS-CoV and supported less-efficient S protein-mediated infection, which implies that a mouse transgenically expressing humanACE2 may be a useful animal model of Sars.
Journal ArticleDOI
Development and Characterization of a Severe Acute Respiratory Syndrome—Associated Coronavirus—Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice
Thomas C. Greenough,Gregory J. Babcock,Anjeanette Roberts,Hector Javier Hernandez,William D. Thomas,Jennifer A. Coccia,Robert F. Graziano,Mohan Srinivasan,Israel Lowy,Robert W. Finberg,Kanta Subbarao,Leatrice Vogel,Mohan Somasundaran,Katherine Luzuriaga,John L. Sullivan,Donna M. Ambrosino +15 more
TL;DR: Human monoclonal antibodies that neutralize SARS-associated coronavirus (SARSCoV) could provide protection for exposed individuals and clinical trials are planned to test MAb 201, a fully human MAb specific for the epitope within the receptor-binding region.
Journal ArticleDOI
Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces
Shivender M.D. Shandilya,Madhavi N. L. Nalam,Ellen A. Nalivaika,Phillip J. Gross,Johnathan C. Valesano,Keisuke Shindo,Ming Li,Mary Munson,William E. Royer,Elena Harjes,Takahide Kono,Hiroshi Matsuo,Reuben S. Harris,Mohan Somasundaran,Celia A. Schiffer +14 more
TL;DR: The crystal structure of the catalytically active C-terminal domain was determined and this structure corroborates features previously observed in nuclear magnetic resonance (NMR) studies, a bulge in the second beta strand and a lengthening of the second alpha helix.